BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20973853)

  • 1. Main reasons for hospital admissions by women with a history of methadone maintenance.
    Burns L; Conroy E; Mattick RP
    Drug Alcohol Rev; 2010 Nov; 29(6):669-75. PubMed ID: 20973853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
    Ngo HT; Tait RJ; Hulse GK
    J Psychopharmacol; 2011 Jun; 25(6):774-82. PubMed ID: 20360157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.
    Carpentier PJ; van Gogh MT; Knapen LJ; Buitelaar JK; De Jong CA
    Eur Addict Res; 2011; 17(1):10-20. PubMed ID: 20881401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of psychiatric severity on the outcome of methadone maintenance treatment.
    Pani PP; Maremmani I; Pacini M; Lamanna F; Maremmani AG; Dell'osso L
    Eur Addict Res; 2011; 17(2):80-9. PubMed ID: 21178355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.
    Pinto H; Maskrey V; Swift L; Rumball D; Wagle A; Holland R
    J Subst Abuse Treat; 2010 Dec; 39(4):340-52. PubMed ID: 20817384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular-associated disease in an addicted population: an observation study.
    Demarie D; Marletta G; Imazio M; Cappa C; Ferro S; Compostino R; De Vivo E; Trinchero R; Bignamini E
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):51-4. PubMed ID: 21135593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study.
    Cousins G; Teljeur C; Motterlini N; McCowan C; Dimitrov BD; Fahey T
    J Subst Abuse Treat; 2011 Oct; 41(3):252-60. PubMed ID: 21696913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New community-based methadone maintenance treatment programs in Guangdong, China, and their impact on patient quality of life.
    He Q; Wang X; Xia Y; Mandel JS; Chen A; Zhao L; Han L; Ling L
    Subst Use Misuse; 2011; 46(6):749-57. PubMed ID: 21114401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program.
    Almario CV; Seligman NS; Dysart KC; Berghella V; Baxter JK
    Am J Obstet Gynecol; 2009 Sep; 201(3):326.e1-6. PubMed ID: 19631928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample.
    Lua PL; Talib NS
    Subst Use Misuse; 2012 Aug; 47(10):1100-5. PubMed ID: 22545914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Were the changes to Sweden's maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity?
    Romelsjö A; Engdahl B; Stenbacka M; Fugelstad A; Davstad I; Leifman A; Thiblin I
    Addiction; 2010 Sep; 105(9):1625-32. PubMed ID: 20626377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of health status in participants from a methadone treatment program in Krakow after one year of maintenance treatment].
    Pach J; Kamenczak A; Maj JC; Foryś Z
    Przegl Lek; 2001; 58(4):240-4. PubMed ID: 11450344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.